Abstract:Gastric cancer (GC) is the fifth most common cancer and the third most common cause of cancer death globally, with high invasiveness, high recurrence rate, and poor prognosis. Multiple studies have shown that Metallothionein-1G (MT1G) is closely associated with oxidative stress, ferroptosis, and autophagy. However, the role and potential mechanisms of MT1G in GC have not been fully elucidated. This study aims to explore the biological functions and regulatory mechanisms of MT1G in GC. Perform bioinformatics analysis using the TCGA database to investigate the expression of MT1G in GC. RT-qPCR and Western blot were used to detect the expression of MT1G, ferroptosis related proteins, autophagy related proteins and ARNTL clock autophagy related proteins in Hgc27, MKN45 and AGS cell lines. Exploring the biological functions of MT1G overexpressing GC cell lines through wound healing and transwell experiments. Use specific fluorescence probes to examine mitochondrial membrane potential and Fe 2+ fluorescence intensity. Using immunoprecipitation analysis (CO-IP) to elucidate the association between GC cell lines GPX4, SQSTM and ARNTL. Use flow cytometry to detect ROS expression. Observation of autophagy related morphological changes in cells using transmission electron microscopy. Compared with gastric mucosal cell lines, the expression of MT1G is decreased in three gastric cancer cell lines (Hgc27, MKN45 and AGS). Overexpression of MT1G inhibits the proliferation, migration, and invasion functions of GC cells, reduces SOD and GSH content, increases MDA content, cause the mitochondrial membrane potential to weaken and promote the transformation of JC-1 aggregates to JC-1 monomer, increases Fe 2+ , affects ROS, and reduces GPX4 and SLC7A11 protein expression, promoting ferroptosis. Overexpression of MT1G promotes the transformation of LC3B I to LC3B II, reduces SQSTM1 protein expression, and leads to the appearance of more autophagosomes and autolysosomes at low magnification. At high magnification, mitochondrial autophagy, endoplasmic reticulum autophagy, lipid droplet autophagy, and wrinkled mitochondrial cristae are observed, promoting autophagy. Overexpression of MT1G inhibits GPX4, thereby affecting SQSTM1 as a vector to promote ARNTL autophagy and EGLN2, promoting ARNTL clock autophagy through the GPX4/SQSTM1 axis. Our research findings elucidate that overexpression of MT1G promotes iron autophagy centered around ARNTL in GC cells via the GPX4/SQSTM1 axis, thereby inhibiting GC cell function and providing a new molecular mechanism and therapeutic target for the development of GC.

MST4 as a novel therapeutic target for autophagy and radiosensitivity in gastric cancer

<scp>MST4</scp> as a novel therapeutic target for autophagy and radiosensitivity in gastric cancer

MST4 Promotes Proliferation, Invasion, and Metastasis of Gastric Cancer by Enhancing Autophagy

MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma

MST4 Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-Mesenchymal Transition in Gastric Cancer

MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer.

The Mammalian Sterile 20-Like Kinase 4 (MST4) Signaling in Tumor Progression: Implications for Therapy

CMTM4 inhibits gastric tumorigenesis and metastasis

ITRAQ-based Bioinformatics Analysis Reveals the Potential Anticancer Effects of ATP4B in Gastric Cancer

Identification and validation of Cystatin A as a novel promising therapeutic target for gastric cancer

High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer

Prognostic Value of Autophagy-related Proteins in Human Gastric Cancer

Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition

Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation

Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells Through Transactivation of SIRT1 Expression

MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors

B3GALT4 modulates tumor progression and autophagy by AKT/mTOR signaling pathway in breast cancer

TLR4 inhibited autophagy by modulating PI3K/AKT/mTOR signaling pathway in Gastric cancer cell lines

Immunotherapy and pan-apoptotic characterization of the tumor microenvironment in gastric cancer (STAD): a single-cell multidimensional analysis

MST4 Promotes Hepatocellular Carcinoma Epithelial-Mesenchymal Transition and Metastasis Via Activation of the P-Erk Pathway.

MT1G promotes iron autophagy and inhibits the function of gastric cancer cell lines by intervening in GPX4/SQSTM1